Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...

A study published in The American Journal of Pathology demonstrates that Piezo2 is a critical mechanoreceptor involved in stiffness-mediated profibrotic fibroblast phenotypes Pulmonary fibrotic ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by ...

Piezo2 is highly expressed in human lung tissue from patients with IPF and in multiple (different) mouse models of lung fibrosis. Piezo2 is highly expressed in primary human lung fibroblasts in ...

Two experimental therapies from Vicore Pharma and Endeavor BioMedicines that could provide new ways of treating idiopathic pulmonary fibrosis (IPF) have shown encouraging results in mid-stage ...